logo

FDA Calendar

Share SHARE
Company Name Johnson & Johnson
Drug Name XARELTO (sNDA)
Event Name FDA decision for a 10 mg dose to reduce the risk of recurrent venous thromboembolism
Event Date 10/28/2017
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar